Pulmonx: Breath of Fresh Air for Lung Disease Patients
Pulmonx Corporation (NASDAQ: LUNG) is a global leader in minimally invasive treatments for severe lung disease. The Company’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System, and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD (chronic obstructive pulmonary disease) who,...
